An Unintended Consequence of the 21st-Century Cures Act for Patients With Heart Failure.
作者信息
Gilstrap Lauren G, DeFilippis Ersilia M, Stevenson Lynne W
机构信息
From Brigham and Women's Hospital, Division of Cardiovascular Medicine (L.G.G., L.W.S.), and Department of Medicine (E.M.D.), Boston, MA; and Harvard Medical School, Department of Health Care Policy, Boston, MA (L.G.G.).
出版信息
Circulation. 2017 Jul 11;136(2):123-125. doi: 10.1161/CIRCULATIONAHA.117.028747.
Abstract
摘要
相似文献
1
An Unintended Consequence of the 21st-Century Cures Act for Patients With Heart Failure.《21世纪治愈法案》给心力衰竭患者带来的意外后果。
Circulation. 2017 Jul 11;136(2):123-125. doi: 10.1161/CIRCULATIONAHA.117.028747.
2
Experts split on 21st Century Cures Act.专家们对《21世纪治愈法案》意见不一。
Lancet Respir Med. 2015 Sep;3(9):676. doi: 10.1016/S2213-2600(15)00330-6. Epub 2015 Aug 23.
3
Health, Wealth, and the 21st Century Cures Act.《健康、财富与21世纪治愈法案》
JAMA Oncol. 2016 Jan;2(1):17-8. doi: 10.1001/jamaoncol.2015.4221.
4
US 21st Century Cures Act secures health-care research funding.美国《21世纪治愈法案》确保了医疗保健研究资金。
Lancet Oncol. 2017 Jan;18(1):24. doi: 10.1016/S1470-2045(16)30636-2. Epub 2016 Dec 13.
5
The 21st Century Cures Act: can the regulatory framework survive the "cures"?《21世纪治愈法案》：监管框架能否经受住“治愈”的考验？
Cad Saude Publica. 2015 Sep;31(9):1807-10. doi: 10.1590/0102-311XPE010915.
6
21st Century Cures Act-A Cure-All for Patients?《21世纪治愈法案》——患者的万灵药？
Am J Nurs. 2016 Jul;116(7):19-20. doi: 10.1097/01.NAJ.0000484926.27907.b4.
7
The 21st Century Cures Act.《21世纪治愈法案》
N Engl J Med. 2015 Oct 22;373(17):1679-80. doi: 10.1056/NEJMc1509640.
8
The 21st Century Cures Act.《21世纪治愈法案》
N Engl J Med. 2015 Oct 22;373(17):1677-8. doi: 10.1056/NEJMc1509640.
9
The 21st Century Cures Act.《21世纪治愈法案》
N Engl J Med. 2015 Oct 22;373(17):1678. doi: 10.1056/NEJMc1509640.
10
The 21st Century Cures Act.《21世纪治愈法案》
N Engl J Med. 2015 Oct 22;373(17):1679. doi: 10.1056/NEJMc1509640.
引用本文的文献
1
National shortage of home intravenous inotrope agents: The "inotrope pandemic" continues.国内家庭用静脉注射强心剂短缺：“强心剂大流行”仍在继续。
JHLT Open. 2023 Nov 19;3:100023. doi: 10.1016/j.jhlto.2023.100023. eCollection 2024 Feb.
2
Dobutamine in the Management of Advanced Heart Failure.多巴酚丁胺在晚期心力衰竭治疗中的应用
J Clin Med. 2024 Jun 27;13(13):3782. doi: 10.3390/jcm13133782.
3
Geographic variation in the use of continuous outpatient inotrope infusion therapy and beta blockers.持续门诊正性肌力药物输注治疗和β受体阻滞剂使用的地域差异。
Int J Cardiol Heart Vasc. 2022 Feb 16;39:100948. doi: 10.1016/j.ijcha.2021.100948. eCollection 2022 Apr.
4
Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials.为什么正性肌力药物在慢性心力衰竭中失败了？来自既往正性肌力药物试验的教训。
Eur J Heart Fail. 2019 Sep;21(9):1064-1078. doi: 10.1002/ejhf.1557. Epub 2019 Aug 13.
5
Ambulatory Inotrope Infusions in Advanced Heart Failure: A Systematic Review and Meta-Analysis.门诊儿茶酚胺输注治疗心力衰竭：系统评价和荟萃分析。
JACC Heart Fail. 2018 Sep;6(9):757-767. doi: 10.1016/j.jchf.2018.03.019. Epub 2018 Jul 11.
本文引用的文献
1
Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.晚期心力衰竭的家庭正性肌力药物治疗：成本分析与临床结局
Chest. 1997 Nov 5;112(5):1298-303. doi: 10.1378/chest.112.5.1298.
Zotero 插件